What clinical trials are available for recurrent Colorectal Cancer

Clinical Trials for Recurrent Colorectal Cancer

I appreciate your question about clinical trial options. While I have access to comprehensive NCCN Guidelines for colorectal cancer treatment, the specific guidelines provided don't include a detailed registry of currently active clinical trials. However, I can explain the treatment landscape and how to find trials that may be relevant to your situation.

Treatment Approaches for Recurrent CRC

According to NCCN Guidelines Version 5.2025 for Colon Cancer, the Panel emphasizes that "treating patients in a clinical trial has priority over standard or accepted therapy." This means clinical trials should be considered as a first-line option alongside standard treatments.

For recurrent colorectal cancer, treatment typically depends on:

Key Factors Your Team Will Consider:

• Previous chemotherapy history - what you've already received
• Biomarker status - specifically:
  • MSI/MMR status (mismatch repair deficiency or microsatellite instability)
  • KRAS/NRAS mutations
  • BRAF mutations
  • HER2 amplifications
• Location and extent of recurrence (local vs. distant metastases)
• Time since initial treatment

General Treatment Categories (Where Trials Often Focus)

According to NCCN Guidelines, systemic therapy options for recurrent/progressive disease include:

Chemotherapy-based approaches:

• FOLFOX, FOLFIRI, FOLFOXIRI combinations
• Fluoropyrimidine monotherapy

Targeted therapies:

• Bevacizumab (anti-angiogenic agent)
• Cetuximab or panitumumab (for KRAS wild-type tumors)
• Regorafenib (for refractory disease)
• TAS-102 (trifluridine-tipiracil)

Immunotherapy (for specific biomarker profiles):

• Nivolumab and ipilimumab combinations (for dMMR/MSI-H tumors)
• Dostarlimab (for mismatch repair deficient tumors)

How to Find Clinical Trials

Official Resources:

1. ClinicalTrials.gov (https://clinicaltrials.gov)

   • Search: "colorectal cancer" + "recurrent" or "metastatic"
   • Filter by location, trial phase, and recruitment status

2. Your Cancer Center's Research Department

   • Ask your oncologist directly about trials they're affiliated with
   • Many academic centers have dedicated trial coordinators

3. Cancer-Specific Resources:

   • American Cancer Society - has trial matching services
   • National Cancer Institute (NCI) - Cancer.gov has trial finder tools
   • NCCN Member Institutions - often have robust trial portfolios

4. Disease Advocacy Organizations:

   • Colorectal Cancer Alliance
   • Fight Colorectal Cancer
   • These often maintain trial databases specific to CRC

Questions to Ask Your Oncologist About Trials

1. "Are there any clinical trials available for my specific biomarker profile (MSI/MMR status, KRAS/BRAF status)?"

2. "What trials is our cancer center currently enrolling for recurrent colorectal cancer?"

3. "Based on my previous treatments, which trial approaches might be most appropriate?"

4. "What are the potential benefits and risks of the trial compared to standard treatment options?"

5. "If I enroll in a trial, can I switch to standard treatment if the trial isn't working?"

6. "How will my progress be monitored, and how often will I need to visit the center?"

Important Context

The NCCN Panel stresses that "recommendations for patients with disseminated metastatic disease represent a continuum of care in which lines of treatment are blurred rather than discrete." This means your treatment plan may evolve based on how your cancer responds, and trials may be available at different points in your treatment journey.

---

Next Steps

I strongly recommend:

1. Ask your oncologist to review your tumor's biomarker results with you
2. Request a list of trials your center is currently enrolling
3. Visit ClinicalTrials.gov and search with your specific diagnosis and biomarker status
4. Contact your local cancer center's research coordinator

Your oncologist will determine which trials are most appropriate for YOUR specific situation based on your complete medical history, previous treatments, and tumor characteristics.

---

This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions about clinical trial participation.